Cargando…
Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection
BACKGROUND AND AIMS: With current standard of care a functional cure for Chronic Hepatitis B (CHB) is only achieved in 1-3% of patients and therefore novel therapies are needed. Disease activity during CHB can be determined by a broad range of virological biomarkers, however these biomarkers are als...
Autores principales: | Loukachov, Vladimir V., van Dort, Karel A., Maurer, Irma, Takkenberg, R. Bart, de Niet, Anniki, Reesink, Henk W., Willemse, Sophie B., Kootstra, Neeltje A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201251/ https://www.ncbi.nlm.nih.gov/pubmed/35719345 http://dx.doi.org/10.3389/fcimb.2022.790964 |
Ejemplares similares
-
Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
por: Erken, Robin, et al.
Publicado: (2022) -
Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing
por: Loukachov, Vladimir, et al.
Publicado: (2022) -
DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
por: Booiman, Thijs, et al.
Publicado: (2015) -
A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients
por: Erken, Robin, et al.
Publicado: (2022) -
Dynamics of the Immune Response in Acute Hepatitis B Infection
por: Stelma, Femke, et al.
Publicado: (2017)